in this issue
EnviroTech :: Biotech
Novozymes Sales and Profits Grow Strongly in 2010
4:45 AM MST | January 24, 2011 | Alex Scott
Enzymes technology company Novozymes (Copenhagen) says its 2010 Ebit increased 25% to DK 2.1 billion ($382 million) on sales up 15% to DK 9.7 billion. Overall demand was high in the enzyme business, and costs were kept under control, the company says. The outlook for 2011 is for an Ebit growth of 8-11% with a corresponding growth in sales of 7-11%. ROIC was 22.2% in 2010, compared with 20.3% in 2009, including goodwill. “We performed very well in terms of sales, earnings, cash flow, and sustainability," says Steen Riisgaard...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee